Having trouble accessing articles? Reset your cache.

Nanoemulsion-adjuvanted influenza vaccine: Phase I data

In a single-blind, active- and placebo-controlled, dose-escalation Phase I trial in 199 healthy volunteers who had not previously received the Fluzone

Read the full 218 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE